SAFETY AND EFFICACY OF SUNITINIB IN AN EXPANDED-ACCESS TRIAL OF METASTATIC RENAL CELL CARCINOMA (MRCC): UPDATED RESULTS AND SUBPOPULATION ANALYSIS

Authors :: G. A. Bjarnason
Se-Hoon Lee
Sergio Bracarda
Cezary Szczylik
Stéphane Oudard
Wilfried Eberhardt
Robert E. Hawkins
M. E. Gore
Camillo Porta
G. Carteni
Source :: European Urology Supplements. 7:246
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Oncology
medicine.medical_specialty
Sunitinib
Renal cell carcinoma
business.industry
Urology
Internal medicine
medicine
Expanded access trial
medicine.disease
business
medicine.drug

Full Text Access

Tools